Evidence map›Paper›PMID 20942910›Full record

ArticleBreast cancer research : BCR2010

A novel approach for the generation of genetically modified mammary epithelial cell cultures yields new insights into TGFβ signaling in the mammary gland.

Ethan A Kohn, Zhijun Du, Misako Sato, Catherine M H Van Schyndle, Michael A Welsh, Yu-an Yang, Christina H Stuelten, Binwu Tang, Wenjun Ju, Erwin P Bottinger and 1 more

Open access · goldAbstract read
In one paragraph

Article in Breast cancer research : BCR, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact, top 90% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. TGF-β signaling in breast cancer cell invasion and bone metastasis.Journal of mammary gland biology and neoplasia · 2011
    Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Ethan A KohnLaboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA.
Zhijun Du
Misako Sato
Catherine M H Van Schyndle
Michael A Welsh
Yu-an Yang
Christina H Stuelten
Binwu Tang
Wenjun Ju
Erwin P Bottinger
Lalage M Wakefield
Cardiff University · GB

Funding

TGF-betas in breast cancer progressionZIABC005785 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI WAKEFIELD, LALAGE · 2009 to 2025
$16.4M
CYTOKINE SIGNALING IN RENAL FIBROSISR01DK056077 · NIDDK · YESHIVA UNIVERSITY · PI BOTTINGER, ERWIN P. · 1999 to 2009
$3.2M
Genetic Programming in Progressive Renal DiseaseR01DK060043 · NIDDK · YESHIVA UNIVERSITY · PI BOTTINGER, ERWIN P. · 2001 to 2010
$2.9M
TGF-betas in breast cancer progressionZ01BC005785 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI WAKEFIELD, LALAGE · 1996 to 2008
$1.9M
Intramural NIH HHSNCI NIH HHS Z01 BC 005785NIDDK NIH HHS R01 DK056077NIDDK NIH HHS R01 DK060043
6 · The paper itself

Abstract

introductionMolecular dissection of the signaling pathways that underlie complex biological responses in the mammary epithelium is limited by the difficulty of propagating large numbers of mouse mammary epithelial cells, and by the inability of ribonucleic acid interference (RNAi)-based knockdown approaches to fully ablate gene function. Here we describe a method for the generation of conditionally immortalized mammary epithelial cells with defined genetic defects, and we show how such cells can be used to investigate complex signal transduction processes using the transforming growth factor beta (TGFβ/Smad pathway as an example.

methodsWe intercrossed the previously described H-2Kb-tsA58 transgenic mouse (Immortomouse) which expresses a temperature-sensitive mutant of the simian virus-40 large T-antigen (tsTAg), with mice of differing Smad genotypes. A panel of conditionally immortalized mammary epithelial cell (IMEC) cultures were derived from the virgin mammary glands of offspring of these crosses and used to assess the Smad dependency of different biological responses to TGFβ.

resultsIMECs could be propagated indefinitely at permissive temperatures and had a stable epithelial phenotype, resembling primary mammary epithelial cells with respect to several criteria, including responsiveness to TGFβ. Using this panel of cells, we demonstrated that Smad3, but not Smad2, is necessary for TGFβ-induced apoptotic, growth inhibitory and EMT responses, whereas either Smad can support TGFβ-induced invasion as long as a threshold level of total Smad is exceeded.

conclusionsThis work demonstrates the practicality and utility of generating conditionally immortalized mammary epithelial cell lines from genetically modified Immortomice for detailed investigation of complex signaling pathways in the mammary epithelium.

Indexed as

Signal TransductionAnimalsApoptosisCell DifferentiationCell MovementCells, CulturedEpithelial CellsEpithelial-Mesenchymal TransitionFemaleGene Knockout TechniquesMammary Glands, AnimalMiceMice, TransgenicSmad2 ProteinSmad3 ProteinTransforming Growth Factor betaSmad2 ProteinSmad2 protein, mouseSmad3 ProteinSmad3 protein, mouseTransforming Growth Factor beta

Identifiers

PMID20942910
PMCPMC3096976
OpenAlexW2014138768

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.